Skip to main content
Toggle navigation
Search
Home
Icon Legend
Presentation Icons
RAPS Focus
Networking Opportunity
Student Focus
RAPS Competency Framework Proficiency Level: Expert
RAPS Competency Framework Proficiency Level: Advanced
RAPS Competency Framework Proficiency Level: Intermediate
RAPS Competency Framework Proficiency Level: Foundational
Ticketed Event
Repeat Session
Invitation-Only Event
Sold Out Ticketed Event
Limited Seating
Full Schedule
Home
Full Schedule
All Days
Mon, Sep 14
Tue, Sep 15
Wed, Sep 16
Thu, Sep 17
Full Schedule
Type here to filter the list
Wednesday, September 16, 2026
6:30 AM - 5:30 PM
EDT
Registration Hours
6:30 AM - 5:30 PM
EDT
Registration Hours
6:30 AM - 5:30 PM
EDT
Speaker Ready Room Hours
6:30 AM - 5:30 PM
EDT
Speaker Ready Room Hours
7:00 AM - 8:00 AM
EDT
Continental Breakfast
7:00 AM - 8:00 AM
EDT
Continental Breakfast
Networking
7:00 AM - 6:00 PM
EDT
RAPS Store Hours
7:00 AM - 6:00 PM
EDT
RAPS Store Hours
8:00 AM - 9:00 AM
EDT
Morning Plenary Session
8:00 AM - 9:00 AM
EDT
Morning Plenary Session
9:15 AM - 10:15 AM
EDT
Advancing Representation in Clinical Trials: Scientific and Operational Strategies for Population-Reflective Enrollment
9:15 AM - 10:15 AM
EDT
Advancing Representation in Clinical Trials: Scientific and Operational Strategies for Population-Reflective Enrollment
Moderator:
Junyang Wang
– EMD Serono
Panelist:
Madhumitha Rengasamy
– Genentech
Panelist:
Vinay Pai, PhD, MBA (he/him/his)
– Health Tequity
Panelist:
Scott D. Schliebner, MPH (he/him/his)
– P1 Pratia Oncology
Pharmaceuticals (includes Biologics and Drugs)
9:15 AM - 10:30 AM
EDT
Back by Popular Demand: The Evolution of US and EU Regulatory Policies and Excellence
9:15 AM - 10:30 AM
EDT
Back by Popular Demand: The Evolution of US and EU Regulatory Policies and Excellence
Moderator:
Amra Racic
– MedTech
Panelist:
Laura DiAngelo, MPH (she/her/hers)
– AgencyIQ
Panelist:
Philip Desjardins, JD
– Arnold Porter
Devices (including Medical Devices & In Vitro Diagnostics)
9:15 AM - 10:30 AM
EDT
Biomarker‑Based Endpoints in Drug Development: Scientific Rigor and Regulatory Perspectives
9:15 AM - 10:30 AM
EDT
Biomarker‑Based Endpoints in Drug Development: Scientific Rigor and Regulatory Perspectives
Presenter:
Sathya Ganesan, PhD, US-RAC (she/her/hers)
– UCB
Presenter:
Vasundhara Pathak, MS, PhD, RAC-Devices, RAC-Drugs
– AstraZeneca
Presenter:
Claudia Dollins, PhD
– GSK
Pharmaceuticals (includes Biologics and Drugs)
9:15 AM - 10:30 AM
EDT
Diverse Women in Regulatory Affairs: Leadership and Career Pathways
9:15 AM - 10:30 AM
EDT
Diverse Women in Regulatory Affairs: Leadership and Career Pathways
Session Leader:
Djuana Banks
– Medtronic
Panelist:
Kamana Singh, DVM, MMB, MBA, RAC-US (she/her/hers)
– APS Pharma Solutions, LLC
Panelist:
Sequita Lindsey, MSRA, RAC-Global, FRAPS
– RAPS North Carolina Local Networking Group
Panelist:
Gabriela Moreira, MBA
– Medtronic
Broad Interest (Cannabidiol, Health-Related Foods, AI, Cybersecurity, Data Transparency, Inspections & Audits)
9:15 AM - 10:30 AM
EDT
Health Authority Forum: Europe Forum, European Medicines Agency (EMA)
9:15 AM - 10:30 AM
EDT
Health Authority Forum: Europe Forum, European Medicines Agency (EMA)
Health Authority Session
9:15 AM - 10:30 AM
EDT
New Session Topic: IVDR Revision Proposal
9:15 AM - 10:30 AM
EDT
IVDR, Quo Vadis? Revising the In Vitro Diagnostics Regulation
Presenter:
Francis Dekker, PhD (she/her/hers)
– ThermoFisher
Presenter:
Gert W. Bos, PhD, FRAPS (he/him/his)
– QServe Group
Presenter:
Marta Carnielli
– TÜV SÜD
Presenter:
Stefan Burde, PhD (he/him/his)
– IVDR Solutions LLC
Devices (including Medical Devices & In Vitro Diagnostics)
9:15 AM - 10:30 AM
EDT
Small Manufacturers: Challenges and Lessons Learned
9:15 AM - 10:30 AM
EDT
Small Manufacturers: Challenges and Lessons Learned
Moderator:
Angelina M. Lisandrelli (she/her/hers)
– Intuitive Surgical
Presenter:
Julien S. Senac, PhD
– TÜV SÜD
Presenter:
Robert Paassen, MSc (he/him/his)
– QServe Group
Devices (including Medical Devices & In Vitro Diagnostics)
10:30 AM - 11:00 AM
EDT
Networking Refreshment Break in Exhibit Hall
10:30 AM - 11:00 AM
EDT
Networking Refreshment Break in Exhibit Hall
Networking
10:30 AM - 1:00 PM
EDT
Exclusive Exhibit Hall Hours: Networking & Presentations
10:30 AM - 1:00 PM
EDT
Exclusive Exhibit Hall Hours: Networking & Presentations
10:30 AM - 4:30 PM
EDT
Exhibit Hall Hours
10:30 AM - 4:30 PM
EDT
Exhibit Hall Hours
10:35 AM - 11:05 AM
EDT
Solutions Circle: Including Regulatory Requirements in Partnership Agreements for Joint Drug and Combination Product Development
10:35 AM - 11:05 AM
EDT
Solutions Circle: Including Regulatory Requirements in Partnership Agreements for Joint Drug and Combination Product Development
Facilitator:
Mary E. Wilhelm, MS, MSRA, DRSc, RAC-EU, RAC-US
– Ascendis Pharma
Broad Interest (Cannabidiol, Health-Related Foods, AI, Cybersecurity, Data Transparency, Inspections & Audits)
Solutions Circle
10:35 AM - 11:05 AM
EDT
Solutions Circle: Maximizing the Potential of Meetings with the FDA
10:35 AM - 11:05 AM
EDT
Solutions Circle: Maximizing the Potential of Meetings with the FDA
Facilitator:
Hagit Marchaim, PhD (she/her/hers)
– HMC-regulation
Pharmaceuticals (includes Biologics and Drugs)
Solutions Circle
10:35 AM - 11:05 AM
EDT
Solutions Circle: QMSR Transition: The Gaps Manufacturers Are Underestimating and How to Prioritize Remediation
10:35 AM - 11:05 AM
EDT
Solutions Circle: QMSR Transition: The Gaps Manufacturers Are Underestimating and How to Prioritize Remediation
Facilitator:
Pujitha P. Gourabathini
– Becton, Dickinson and Company
Solutions Circle
11:15 AM - 11:45 AM
EDT
Solutions Circle: FDA Pre-Submission Strategy: How to Plan, Execute, and Maximize Regulatory Feedback
11:15 AM - 11:45 AM
EDT
Solutions Circle: FDA Pre-Submission Strategy: How to Plan, Execute, and Maximize Regulatory Feedback
Facilitator:
Akash Kirani
– MelioLabs Inc
Devices (including Medical Devices & In Vitro Diagnostics)
Solutions Circle
11:15 AM - 11:45 AM
EDT
Solutions Circle: The Invisible Dossier: Networking as a Regulatory Requirement
11:15 AM - 11:45 AM
EDT
Solutions Circle: The Invisible Dossier: Networking as a Regulatory Requirement
Facilitator:
Jasmine G. Muse, MSci, MS RAQA (she/her/hers)
– Regulatory Affairs Professional
Skill Building
Solutions Circle
11:15 AM - 11:45 AM
EDT
Solutions Circle: When is the Same Moiety Different? The Clinical Superiority Provisions of FDA's Orphan Drug Regulations
11:15 AM - 11:45 AM
EDT
Solutions Circle: When is the Same Moiety Different? The Clinical Superiority Provisions of FDA's Orphan Drug Regulations
Facilitator:
Timothy Cote, MD, MPH (he/him/his)
– Only Orphans Cote, LLC
Pharmaceuticals (includes Biologics and Drugs)
11:30 AM - 1:00 PM
EDT
Networking Lunch in Exhibit Hall
11:30 AM - 1:00 PM
EDT
Networking Lunch in Exhibit Hall
Networking
11:55 AM - 12:25 PM
EDT
Solutions Circle: Breakthrough Designation: Is It Right for Your Device?
11:55 AM - 12:25 PM
EDT
Solutions Circle: Breakthrough Designation: Is It Right for Your Device?
Facilitator:
Lavanya Ramnath (she/her/hers)
– Insulet
Devices (including Medical Devices & In Vitro Diagnostics)
Solutions Circle
11:55 AM - 12:25 PM
EDT
Solutions Circle: The US Reimbursement Landscape: Understanding Shifts and Changes in the Drug Pricing Narrative
11:55 AM - 12:25 PM
EDT
Solutions Circle: The US Reimbursement Landscape: Understanding Shifts and Changes in the Drug Pricing Narrative
Facilitator:
Mallory O'Connor, MPH
– Keenova
Pharmaceuticals (includes Biologics and Drugs)
Solutions Circle
11:55 AM - 12:25 PM
EDT
Solutions Circle: The Volunteer Sandbox: Accelerating Regulatory Leadership through RAPS
11:55 AM - 12:25 PM
EDT
Solutions Circle: The Volunteer Sandbox: Accelerating Regulatory Leadership through RAPS
Facilitator:
Ankita Joshi, MBA, MS
– Recor Medical, Inc.
Skill Building
Solutions Circle
1:00 PM - 2:00 PM
EDT
Animal Health Drugs: The Approval and Lifecycle Process
1:00 PM - 2:00 PM
EDT
Animal Health Drugs: The Approval and Lifecycle Process
Moderator:
Karen R. Zimm, RAC-US
– Temple University
Presenter:
Grace Gowda, RAC
– University of Georgia
Presenter:
Elizabeth Norton, DVM (she/her/hers)
– Edge Animal Health, Inc
Pharmaceuticals (includes Biologics and Drugs)
1:00 PM - 2:00 PM
EDT
Clinical Data Transferability: Strategies for Utilizing Cross-Regional Evidence in Regulatory Submissions
1:00 PM - 2:00 PM
EDT
Clinical Data Transferability: Strategies for Utilizing Cross-Regional Evidence in Regulatory Submissions
Panelist:
Leslie Hammermueller (she/her/hers)
– AKRA TEAM GmbH
Panelist:
Richard G. Holborow (he/him/his)
– BSI
Panelist:
Jessica Addison
– Cerapedics, Inc.
Panelist:
Daniel Caños, PhD, MPH
– US Food and Drug Administration
Devices (including Medical Devices & In Vitro Diagnostics)
1:00 PM - 2:00 PM
EDT
Leveraging External Controls to Advance Global Regulatory Decision-Making
1:00 PM - 2:00 PM
EDT
Leveraging External Controls to Advance Global Regulatory Decision-Making
Moderator:
Xiaofei Wang
– Duke University
Presenter:
Neal Storm, DRSc, MS, MBA, RAC (he/him/his)
– Amgen
Pharmaceuticals (includes Biologics and Drugs)
1:00 PM - 2:00 PM
EDT
MDR/IVDR State of Play
1:00 PM - 2:00 PM
EDT
MDR/IVDR State of Play
Moderator:
Bassil Akra, PhD (he/him/his)
– Akra Team
Presenter:
Sabina L. Hoekstra, PharmD, FRAPS
– TÜV SÜD Medical Health Services
Presenter:
Gert W. Bos, PhD, FRAPS (he/him/his)
– QServe Group
Presenter:
Erik R. Vollebregt
– Axon Lawyers
Devices (including Medical Devices & In Vitro Diagnostics)
1:00 PM - 2:00 PM
EDT
New Session Topic: China Device Updates
1:00 PM - 2:00 PM
EDT
China Medtech Session: Latest Updates and Hot Topics From Pre- to Postmarket
Presenter:
Hamish King, LLB, RAC-Devices
– Cisema
Presenter:
Qianqian Zhu, MBA, LLM, RAC-Devices
– Intuitive Surgical, Inc.
Presenter:
Grace F. Palma, MBA (she/her/hers)
– China Med Device
Devices (including Medical Devices & In Vitro Diagnostics)
1:00 PM - 2:00 PM
EDT
New Session Topic: CMC
1:00 PM - 2:00 PM
EDT
The Regulatory Evolution: Navigating the Regulatory Frontier for Next-Generation Oligonucleotides, mRNA and CRISPR Therapies
Presenter:
Kok-Seong Lim, BPharm, PhD, RAC
– Eight Crest Strategies
Presenter:
Melanie Sorensen
– Cytiva
Presenter:
Ashleigh C. Dawley, RAC
– Integrated DNA Technologies, Inc., a Danaher Company
Pharmaceuticals (includes Biologics and Drugs)
1:00 PM - 2:00 PM
EDT
Regulatory Mentoring in the Workplace
1:00 PM - 2:00 PM
EDT
Regulatory Mentoring in Action
Moderator:
Meghan McGovern, MS, RAC-US, RAC-Devices
– AZ Technica
Presenter:
Katrina Peron, MS, RAC
– Critical Path Institute
Skill Building
2:15 PM - 3:15 PM
EDT
Financial Literacy for Regulatory Affairs
2:15 PM - 3:15 PM
EDT
Financial Literacy for Regulatory Affairs
Presenter:
Susan Speicher, BS, MS, RAC-US
– Speicher Regulatory Services
Skill Building
2:15 PM - 3:15 PM
EDT
How AI is Impacting the Regulatory Workforce
2:15 PM - 3:15 PM
EDT
How AI is Impacting the Regulatory Workforce
Presenter:
Brian Scogland
– Veeva Systems
Presenter:
Adam Menzies
– TÜV SÜD
Presenter:
Daniel Prell, MBA, Dr. (he/him/his)
– Siemens Healthineers AG
Devices (including Medical Devices & In Vitro Diagnostics)
2:15 PM - 3:15 PM
EDT
In-Silico Trials: Global Perspectives and Solutions
2:15 PM - 3:15 PM
EDT
In-Silico Trials: Global Perspectives and Solutions
Moderator:
Marc Horner
– Synopsys
Presenter:
Surash Surash, FRCS (Neuro.Surg), MD, LLM
– TÜV SÜD
Presenter:
Christopher Basciano
– Becton Dickinson
Presenter:
Mark J. Grumbridge, BSc PG Dip RGN FTOPRA (he/him/his)
– MHRA
Devices (including Medical Devices & In Vitro Diagnostics)
2:15 PM - 3:15 PM
EDT
New Approach Methodologies (NAMs) in Preclinical Drug Development: The Current Global Regulatory Landscape
2:15 PM - 3:15 PM
EDT
New Approach Methodologies (NAMs) in Preclinical Drug Development: The Current Global Regulatory Landscape
Presenter:
Tyler C. Vandivort, PhD, DABT, RAC-Drugs
– UCB Pharma
Presenter:
Patricia T. Ha
– OBI Pharma USA Inc.
Pharmaceuticals (includes Biologics and Drugs)
2:15 PM - 3:15 PM
EDT
New Session Topic: Direct to Consumer
2:15 PM - 3:15 PM
EDT
FDA’s “Crackdown” on Direct-to-Consumer Prescription Drug Advertising: One Year Later
Panelist:
Kamana Singh, DVM, MMB, MBA, RAC-US (she/her/hers)
– APS Pharma Solutions, LLC
Panelist:
Jason Cober, BA, MPA
– Propharma Group
Panelist:
Virginia Foley, BA (she/her/hers)
– Compliance Forward, LLC
Panelist:
Alexander Gaffney, MS, RAC-US (he/him/his)
– AgencyIQ
Pharmaceuticals (includes Biologics and Drugs)
2:15 PM - 3:15 PM
EDT
New Session Topic: MDR Transition
2:15 PM - 3:15 PM
EDT
New Session Topic: MDR Transition
Moderator:
Sabina L. Hoekstra, PharmD, FRAPS
– TÜV SÜD Medical Health Services
Presenter:
Gert W. Bos, PhD, FRAPS (he/him/his)
– QServe Group
Presenter:
Bassil Akra, PhD (he/him/his)
– Akra Team
Presenter:
Ehab Amen (he/him/his)
– GMED North America, Inc.
Devices (including Medical Devices & In Vitro Diagnostics)
2:15 PM - 3:15 PM
EDT
Sticky Wickets in Statutory Authority: CDER’s Workarounds, Remote Participation, and the Legal Limits of FDA Inspection Power
2:15 PM - 3:15 PM
EDT
Sticky Wickets in Statutory Authority: CDER’s Workarounds, Remote Participation, and the Legal Limits of FDA Inspection Power
Presenter:
H. Joy Sharp, JD
– Exela Pharma Sciences
Pharmaceuticals (includes Biologics and Drugs)
3:15 PM - 3:45 PM
EDT
Networking Refreshment Break in Exhibit Hall
3:15 PM - 3:45 PM
EDT
Networking Refreshment Break in Exhibit Hall
Networking
3:15 PM - 4:30 PM
EDT
Exclusive Exhibit Hall Hours: Networking & Presentations
3:15 PM - 4:30 PM
EDT
Exclusive Exhibit Hall Hours: Networking & Presentations
3:20 PM - 3:50 PM
EDT
Solutions Circle: From Access to Insight: A Call for Transparency and Disclosure
3:20 PM - 3:50 PM
EDT
Solutions Circle: From Access to Insight: A Call for Transparency and Disclosure
Facilitator:
Honz Slipka, MSc
– Veristat
Pharmaceuticals (includes Biologics and Drugs)
Solutions Circle
3:20 PM - 3:50 PM
EDT
Solutions Circle: Reg Ops to Reg Strategy and Everything in Between: How to Become a Well-Rounded RA Professional
3:20 PM - 3:50 PM
EDT
Solutions Circle: Reg Ops to Reg Strategy and Everything in Between: How to Become a Well-Rounded RA Professional
Facilitator:
Amar Chanani, RAC-Devices, PMP, CMQ/OE, CSQE, CRE, CQE, CQA (he/him/his)
– QARA Solutions, LLC
Skill Building
Solutions Circle
3:20 PM - 3:50 PM
EDT
Solutions Circle: Submission Strategies for Medical Devices in Brazil - Submission Pathways & Ongoing Challenges
3:20 PM - 3:50 PM
EDT
Solutions Circle: Submission Strategies for Medical Devices in Brazil - Submission Pathways & Ongoing Challenges
Facilitator:
Natalia Lucena (she/her/hers)
– Vera Rosas Group
Devices (including Medical Devices & In Vitro Diagnostics)
Solutions Circle
3:55 PM - 4:25 PM
EDT
Solutions Circle: How to 10x Productivity as a Regulatory Affairs Professional using AI
3:55 PM - 4:25 PM
EDT
Solutions Circle: How to 10x Productivity as a Regulatory Affairs Professional using AI
Facilitator:
Mihikaa Jain, MTM
– Artos
Skill Building
Solutions Circle
3:55 PM - 4:25 PM
EDT
Solutions Circle: Navigating Social Media in Pharmacovigilance: Regulatory Uncertainty, Data Challenges, and Strategic Considerations
3:55 PM - 4:25 PM
EDT
Solutions Circle: Navigating Social Media in Pharmacovigilance: Opportunities, Challenges, and the Future of Signal Detection
Facilitator:
Elaine Lippmann, JD
– Leavitt Partners
Pharmaceuticals (includes Biologics and Drugs)
Solutions Circle
3:55 PM - 4:25 PM
EDT
Solutions Circle: Risk Assessment: Common Failures in Identification and Implementation of ISO 14971 as Seen by Notified Bodies
3:55 PM - 4:25 PM
EDT
Solutions Circle: Risk Assessment: Common Failures in Identification and Implementation of ISO 14971 as Seen by Notified Bodies
Facilitator:
Mingxiang Xu
– SGS
Solutions Circle
4:30 PM - 5:30 PM
EDT
Conversations That Matter - Interactions With Health Authorities: Drugs, Biologics and Combination Products
4:30 PM - 5:30 PM
EDT
Conversations That Matter - Interactions With Health Authorities: Drugs, Biologics and Combination Products
Health Authority Session
Pharmaceuticals (includes Biologics and Drugs)
4:30 PM - 5:30 PM
EDT
FemTech and Beyond: Addressing Sex-Based Disparities in Medical Devices and Pharmaceuticals
4:30 PM - 5:30 PM
EDT
FemTech and Beyond: Addressing Sex-Based Disparities in Medical Devices and Pharmaceuticals
Presenter:
Angelina M. Lisandrelli (she/her/hers)
– Intuitive Surgical
Presenter:
Marina Daineko, MSc (she/her/hers)
– EPAM Systems
Presenter:
Deidre Washington
– AdvaMed
Devices (including Medical Devices & In Vitro Diagnostics)
4:30 PM - 5:30 PM
EDT
Global Biosimilarity Assessments: Key Regulatory Changes Impacting Biosimilar Development Strategy
4:30 PM - 5:30 PM
EDT
Global Biosimilarity Assessments: Key Regulatory Changes Impacting Biosimilar Development Strategy
Presenter:
Kirsten Messmer, RAC-US
– KM Intel LLC
Presenter:
Melanie Sorensen
– Cytiva
Pharmaceuticals (includes Biologics and Drugs)
4:30 PM - 5:30 PM
EDT
ICH M4Q(R2) as the Inflection Point: Digitizing CMC Submissions and Operationalizing Responsible AI/ML
4:30 PM - 5:30 PM
EDT
ICH M4Q(R2) as the Inflection Point: Digitizing CMC Submissions and Operationalizing Responsible AI/ML
Moderator:
Sai P. Bhamidipati (she/her/hers)
– Moderna, Inc.
Presenter:
Colin D. White (he/him/his)
– Middlesex Consulting Group
Presenter:
Lawrence Yu
– FDA / CDER / OPQ / OPQAII
Presenter (Remote):
Omar Tounekti, PhD (he/him/his)
– Biologic and Radiopharmaceutical Drugs Directorate / Health Canada
Pharmaceuticals (includes Biologics and Drugs)
4:30 PM - 5:30 PM
EDT
Navigating Global eIFU Excellence: Leveraging US and EU Best Practices for Strategic Implementation
4:30 PM - 5:30 PM
EDT
Navigating Global eIFU Excellence: Leveraging US and EU Best Practices for Strategic Implementation
Moderator:
Muna Kebede, M.Sc. / Dipl. Biol.
– AKRA TEAM GmbH
Panelist:
Diane M. Legere, RN (R), BScN (hons), MSc (she/her/hers)
– DNV Business Assurance USA Inc.
Panelist:
Ardi Batmanghelidj (he/him/his)
– Innovatum Inc.
Panelist:
Roger Peterson, MSc
– Arthrex
Panelist:
Michael Kania
– meddevo
Devices (including Medical Devices & In Vitro Diagnostics)
4:30 PM - 5:30 PM
EDT
New Session Topic: Accelerated Drug Development
4:30 PM - 5:30 PM
EDT
New Session Topic: Accelerated Drug Development
Presenter:
Sacha Lynch, MSc
– QbD Group
Presenter:
Allison Martin, MS (she/her/hers)
– Sanofi
Presenter:
Ariane Teyssou, PharmD (she/her/hers)
– Ipsen
Pharmaceuticals (includes Biologics and Drugs)
4:30 PM - 5:30 PM
EDT
New Session Topic: EUDAMED
4:30 PM - 5:30 PM
EDT
Managing Global UDI Compliance Ahead of EUDAMED Implementation: Implications for Regulatory Information Management
Presenter:
Lionel Tussau
– osapiens
Moderator:
Jay Crowley, MS
– USDM Life Sciences
Presenter:
Diogo Geraldes, PhD MEng
– Veeva MedTech
Presenter:
Shereen Bienz (she/her/hers)
– Smith+Nephew
Presenter:
Vishal Thakker, MEng (he/him/his)
– BSI
Devices (including Medical Devices & In Vitro Diagnostics)
4:30 PM - 5:30 PM
EDT
The Convergence of Regulatory and Politics: A Closer Look at Congressional Proposals to Reform FDA
4:30 PM - 5:30 PM
EDT
The Convergence of Regulatory and Politics: A Closer Look at Congressional Proposals to Reform FDA
Moderator:
Alexander Gaffney, MS, RAC-US (he/him/his)
– AgencyIQ
Presenter:
Laura DiAngelo, MPH (she/her/hers)
– AgencyIQ
Broad Interest (Cannabidiol, Health-Related Foods, AI, Cybersecurity, Data Transparency, Inspections & Audits)
5:45 PM - 7:15 PM
EDT
Honoring Excellence: RAPS 2026 Awards Celebration (Invitation Only)
5:45 PM - 7:15 PM
EDT
Honoring Excellence: RAPS 2026 Awards Celebration (Invitation Only)
7:30 PM - 10:00 PM
EDT
Convergence Networking Party (Offsite Event, Location to Be Announced Soon)
7:30 PM - 10:00 PM
EDT
Convergence Networking Party at Monarch Market (Separate Ticket Purchase Required to Attend)
Networking